In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kmart restructuring

This article was originally published in The Rose Sheet

Executive Summary

Gregg Treadway appointed exec VP, store operations to head new field organizational structure, effective immediately, retailer announces Feb. 5. Formerly senior VP-Midwest division, Treadway will report to CEO Chuck Conaway. New structure includes five separate operating divisions - four geographical regions and one Super Center division rather than six geographical field locations. Newly appointed division presidents report to Treadway. Paul Hueber to International Division; Michael Jardina to Super Centers Division; Douglas Meissner to Northeast Division; Lee Viliborghi to West Division; and William Wulfers to Southeast Division. Move marks first step towards reorganization after retailer filed for Chapter 11 Jan. 22 (1"The Rose Sheet" Jan. 28, 2002, p. 7)...

You may also be interested in...



Kmart Reorganization Effort Backed With $2 Bil. Loan

Kmart will finance a "fast-track" reorganization effort under Chapter 11 bankruptcy protection with a $2 bil. financing facility, the Troy, Mich. retailer announced Jan. 22

Chinese Firms Up Their Game In Novel Flu Antiviral Development

Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.

Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel